Nisa Investment Advisors’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $107K | Sell |
1,027
-20
| -2% | -$2.09K | ﹤0.01% | 1372 |
|
|
2025
Q1 | $122K | Sell |
1,047
-26
| -2% | -$3.03K | ﹤0.01% | 1346 |
|
|
2024
Q4 | $90.8K | Buy |
1,073
+50
| +5% | +$4.23K | ﹤0.01% | 1500 |
|
|
2024
Q3 | $91.9K | Buy |
1,023
+37
| +4% | +$3.33K | ﹤0.01% | 1470 |
|
|
2024
Q2 | $79.4K | Buy |
986
+39
| +4% | +$3.14K | ﹤0.01% | 1533 |
|
|
2024
Q1 | $75.6K | Buy |
947
+26
| +3% | +$2.08K | ﹤0.01% | 1554 |
|
|
2023
Q4 | $73.3K | Buy |
921
+5
| +0.5% | +$398 | ﹤0.01% | 1529 |
|
|
2023
Q3 | $64K | Hold |
916
| – | – | ﹤0.01% | 1657 |
|
|
2023
Q2 | $65.8K | Buy |
916
+90
| +11% | +$6.47K | ﹤0.01% | 1650 |
|
|
2023
Q1 | $51K | Hold |
826
| – | – | ﹤0.01% | 1708 |
|
|
2022
Q4 | $64K | Hold |
826
| – | – | ﹤0.01% | 1695 |
|
|
2022
Q3 | $37K | Sell |
826
-62
| -7% | -$2.78K | ﹤0.01% | 1850 |
|
|
2022
Q2 | $34K | Buy |
888
+600
| +208% | +$23K | ﹤0.01% | 1867 |
|
|
2022
Q1 | $12K | Sell |
288
-1,790
| -86% | -$74.6K | ﹤0.01% | 2161 |
|
|
2021
Q4 | $57K | Buy |
2,078
+1,588
| +324% | +$43.6K | ﹤0.01% | 1690 |
|
|
2021
Q3 | $16 | Sell |
490
-2,181
| -82% | -$71 | ﹤0.01% | 2131 |
|
|
2021
Q2 | $180 | Sell |
2,671
-250
| -9% | -$17 | ﹤0.01% | 1447 |
|
|
2021
Q1 | $165 | Hold |
2,921
| – | – | ﹤0.01% | 1545 |
|
|
2020
Q4 | $238K | Buy |
2,921
+1,206
| +70% | +$98.3K | ﹤0.01% | 1399 |
|
|
2020
Q3 | $122K | Sell |
1,715
-797
| -32% | -$56.7K | ﹤0.01% | 1488 |
|
|
2020
Q2 | $207K | Buy |
2,512
+2,292
| +1,042% | +$189K | ﹤0.01% | 1275 |
|
|
2020
Q1 | $13K | Sell |
220
-80
| -27% | -$4.73K | ﹤0.01% | 1798 |
|
|
2019
Q4 | $31K | Hold |
300
| – | – | ﹤0.01% | 1611 |
|
|
2019
Q3 | $6K | Buy |
+300
| New | +$6K | ﹤0.01% | 1870 |
|